We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Pain Reliever from Snail Venom

By Biotechdaily staff writers
Posted on 15 Jul 2002
Researchers have discovered that a compound from a toxic marine snail, an often deadly mollusk found on the Great Barrier Reef, is more powerful and longer lasting than morphine but is not addictive and lacks morphine's side effects. The discovery was announced at the annual meeting of the International Society for Toxicology in Cairns, Australia.

The compound, called ACV1, is made from the venom of a cone shell. It treats pain by blocking the transmission of pain along the peripheral nervous system, say the researchers, from the University of Melbourne (Australia; www.unimelb.edu.au). At least one other company has already developed a drug for pain from a cone shell toxin (conotoxin), but it has shown side effects that include raised blood pressure. ACV1 acts on a different class of pain receptors and is unlikely to exhibit the same side effects.

"ACV1 is a tiny molecule compared to competing conotoxin drugs, making it easier and cheaper to synthesize,” said Bruce Livett, team leader and an associate professor in the department of biochemistry and molecular biology at the University of Melbourne. "Competing drugs also need to be injected into the spinal column. ACV1 can be injected into the muscle or fat layer of patients, making it available to a wider group of patients and an advantage when recruiting patients for clinical trials.”




Related Links:
U. of Melbourne

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Rapid Sepsis Test
SeptiCyte RAPID

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
15 Jul 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
15 Jul 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
15 Jul 2002  |   BioResearch